Skip to content
Inciteful Med

Navigating Prenatal and Postnatal Testing

Last updated:

Down syndrome testing involves screening tests like NIPT that estimate risk, and diagnostic tests like CVS, amniocentesis, or postnatal karyotypes that confirm the condition. A positive NIPT requires diagnostic follow-up, as false positives can occur.

Key Takeaways

  • • NIPT is a highly sensitive screening test for Trisomy 21, but a positive result requires follow-up as it is not a definitive diagnosis.
  • • False positives on an NIPT can happen due to factors like confined placental mosaicism or a vanishing twin.
  • • Invasive diagnostic tests like CVS and amniocentesis provide conclusive prenatal answers but carry a small risk of pregnancy loss.
  • • A G-banded chromosomal karyotype is the definitive postnatal test used to confirm Down syndrome and identify its specific genetic type.
  • • Preliminary postnatal test results can often be obtained in 24 to 48 hours using Rapid FISH testing.

(Note: If your baby has already arrived, you can skip ahead to the Postnatal Confirmation section.)

The journey to a Down syndrome diagnosis can happen before or after a baby is born. Understanding the different types of tests—and what their results actually mean—can help you feel more grounded as you make decisions for your family. Testing is generally divided into two categories: screening tests, which estimate the chance of a condition, and diagnostic tests, which provide a definitive “yes” or “no” answer.

Prenatal Screening: The NIPT

The most common screening tool today is Non-Invasive Prenatal Testing (NIPT), also known as cell-free DNA screening [1]. This is a simple blood test that looks at tiny fragments of DNA from the placenta that circulate in the mother’s blood [2].

  • Accuracy: NIPT is incredibly sensitive, detecting over 99% of cases of Trisomy 21 [3][4].
  • The “False Positive” Puzzle: While a positive NIPT for Down syndrome is highly accurate, it is a screening test, not a diagnosis [5]. The chance that a positive result is actually a true positive (called the Positive Predictive Value, or PPV) depends heavily on the mother’s age and baseline risk. For older mothers or those at higher risk, the PPV can be between 78% and 96%, but it can be significantly lower for younger women [6]. Sometimes the test can be “wrong.” This is often due to Confined Placental Mosaicism (CPM)—a situation where the extra 21st chromosome exists in the placenta but not in the baby [7][8]. Other factors, like maternal health or even a “vanishing twin,” can also lead to discordant results [9][10].

Prenatal Diagnosis: Invasive Testing

If a screening test is positive, or if you want a definitive answer during pregnancy, a diagnostic test is required. These tests involve collecting a sample of cells directly from the pregnancy.

  • Chorionic Villus Sampling (CVS): Usually performed between 10 and 13 weeks of pregnancy, this test samples tissue from the placenta [11]. The estimated risk of pregnancy loss is approximately 0.35% to 1.25%, depending on the study and the specialist’s experience [12][13].
  • Amniocentesis: Performed after 15 weeks, this test samples the amniotic fluid surrounding the baby [14]. Because it tests the fluid the baby is in (rather than the placenta), it is considered the “gold standard” for accuracy [13]. The risk of loss is slightly lower than CVS, often cited around 0.35% to 0.5% [12][13]. Recent studies suggest these risks may be as low as 0.1% to 0.2% when performed by experienced doctors [15].

Postnatal Confirmation: The Karyotype

Whether or not prenatal testing was done, a diagnosis is often confirmed after birth if a baby shows physical characteristics of Down syndrome.

The definitive test is a G-banded chromosomal karyotype [16]. This is a blood test where scientists look at the baby’s chromosomes under a microscope to count them and check their structure [16][17].

  • Timeline: While a full karyotype can take 1 to 2 weeks because cells must be grown in a lab, a preliminary test called Rapid FISH can often provide results for common trisomies within 24 to 48 hours [18][19].
  • Completeness: The full karyotype is essential because it identifies the specific genetic type (Trisomy 21, Translocation, or Mosaicism), which is vital for understanding your child’s medical needs and planning for the future [16].

No matter where you are in this process, remember that these tests are tools designed to give you information and help you prepare for your child’s arrival and care.

Frequently Asked Questions

What does a positive NIPT result for Down syndrome mean?
A positive NIPT means there is a high chance your baby has Down syndrome, but it is a screening test, not a definitive diagnosis. The actual likelihood, called the positive predictive value, depends heavily on the mother's age and baseline risk factors.
Can a positive NIPT result for Down syndrome be wrong?
Yes, false positives can occur. A common cause is confined placental mosaicism, where the extra chromosome is present in the placenta but not in the baby. Factors like maternal health or a vanishing twin can also cause inaccurate screening results.
What is the difference between CVS and amniocentesis?
Chorionic Villus Sampling (CVS) is performed earlier, between 10 and 13 weeks, using placental tissue. Amniocentesis is done after 15 weeks using amniotic fluid and is considered the gold standard for diagnostic accuracy. Both carry a very small risk of pregnancy loss.
How is Down syndrome officially diagnosed after birth?
After birth, doctors use a blood test called a G-banded chromosomal karyotype to count and check the structure of the baby's chromosomes. While this full test takes 1 to 2 weeks, a preliminary Rapid FISH test can often provide initial results within 24 to 48 hours.
Why is a full karyotype test necessary if the baby already shows signs of Down syndrome?
A full karyotype identifies the exact genetic type of Down syndrome, whether it is Trisomy 21, Translocation, or Mosaicism. Knowing the specific type is vital for understanding your child's medical needs and for future family planning.

Questions for Your Doctor

  • • My NIPT was positive, but I've heard it's a screening test—what is the specific 'Positive Predictive Value' for someone of my age?
  • • If we choose invasive testing, what is the current miscarriage risk at this hospital for CVS versus amniocentesis?
  • • Is there any evidence of 'Confined Placental Mosaicism' that could explain a false positive on the NIPT?
  • • After birth, how quickly can we get the results of the 'Rapid FISH' test and the final G-banded karyotype?
  • • If the baby has a translocation, will we also need to be tested for genetic carrier status?

Questions for You

  • • How would having a definitive diagnosis now, versus waiting until birth, change my feelings or my preparation?
  • • Do I feel like I have enough information about the risks and benefits of invasive testing to make a decision that feels right for my family?
  • • Who is my primary support person for processing these test results, and do they have the information they need to support me?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Amniotic fluid stem cells and the cell source repertoire for non-invasive prenatal testing.

    Rosner M, Kolbe T, Voronin V, Hengstschläger M

    Stem cell reviews and reports 2022; (18(4)):1366-1371 doi:10.1007/s12015-021-10228-5.

    PMID: 34383184
  2. 2

    Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration.

    Van Opstal D, Srebniak MI

    Expert review of molecular diagnostics 2016; (16(5)):513-20 doi:10.1586/14737159.2016.1152890.

    PMID: 26864482
  3. 3

    Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.

    Lee DE, Kim H, Park J, et al.

    Journal of Korean medical science 2019; (34(24)):e172 doi:10.3346/jkms.2019.34.e172.

    PMID: 31222985
  4. 4

    [The value of non-invasive prenatal testing for the identification of fetal chromosome aneuploidies].

    Zhou Y, Wang Z, Mao Q, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019; (36(11)):1094-1096 doi:10.3760/cma.j.issn.1003-9406.2019.11.009.

    PMID: 31703133
  5. 5

    Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.

    Liu Y, Liu H, He Y, et al.

    Human genomics 2020; (14(1)):21 doi:10.1186/s40246-020-00268-2.

    PMID: 32503639
  6. 6

    Comparison of the performance of NIPT and NIPT-plus for fetal chromosomal aneuploidy and high Z-score increases the positive predictive value.

    Liu S, Xu Y, Chang Q, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2024; (167(1)):273-280 doi:10.1002/ijgo.15535.

    PMID: 38651210
  7. 7

    Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling.

    Feresin A, Stampalija T, Cappellani S, et al.

    Frontiers in genetics 2022; (13()):982508 doi:10.3389/fgene.2022.982508.

    PMID: 36386832
  8. 8

    Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13.

    Suzumori N, Sekizawa A, Takeda E, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2021; (256()):75-81 doi:10.1016/j.ejogrb.2020.10.050.

    PMID: 33171421
  9. 9

    Cell-free DNA Screening for Aneuploidy.

    Norton ME

    Clinical obstetrics and gynecology 2023; (66(3)):557-567 doi:10.1097/GRF.0000000000000796.

    PMID: 37650668
  10. 10

    Discordant non-invasive prenatal testing (NIPT) - a systematic review.

    Hartwig TS, Ambye L, Sørensen S, Jørgensen FS

    Prenatal diagnosis 2017; (37(6)):527-539 doi:10.1002/pd.5049.

    PMID: 28382695
  11. 11

    Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.

    Zelig CM, Knutzen DM, Ennen CS, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2016; (38(5)):441-445.e2.

    PMID: 27261219
  12. 12

    Amniocentesis and chorionic villus sampling for prenatal diagnosis.

    Alfirevic Z, Navaratnam K, Mujezinovic F

    The Cochrane database of systematic reviews 2017; (9()):CD003252 doi:10.1002/14651858.CD003252.pub2.

    PMID: 28869276
  13. 13

    Invasive prenatal diagnosis in the era of cell-free fetal DNA: experience at a single center.

    Ponziani I, Pallottini M, Masini G, et al.

    Minerva obstetrics and gynecology 2023; (75(5)):393-398 doi:10.23736/S2724-606X.22.05042-4.

    PMID: 37768256
  14. 14

    Traditional Prenatal Diagnosis: Past to Present.

    Levy B, Stosic M

    Methods in molecular biology (Clifton, N.J.) 2019; (1885()):3-22 doi:10.1007/978-1-4939-8889-1_1.

    PMID: 30506187
  15. 15

    Whole-Chromosome Karyotyping of Fetal Nucleated Red Blood Cells Using the Ion Proton Sequencing Platform.

    Barrett AN, Huang Z, Aung S, et al.

    Genes 2022; (13(12)) doi:10.3390/genes13122257.

    PMID: 36553524
  16. 16

    Comprehensive Cytogenetic Analysis Reveals Mosaicism in Newborn with Negative Prenatal Down Syndrome Screening: A Case Report.

    Puppo I, Vardanyan A, Shahsuvaryan G, et al.

    The American journal of case reports 2025; (26()):e948522 doi:10.12659/AJCR.948522.

    PMID: 40864624
  17. 17

    Experience of the Pediatric Department at the Mohammed VI University Hospital Center in Oujda on Trisomy 21 and Congenital Heart Defects: What Is the Reality in the Oriental Region of Morocco?

    Babakhouya A, Yechouti C, Salhi C, et al.

    Cureus 2025; (17(6)):e86689 doi:10.7759/cureus.86689.

    PMID: 40718231
  18. 18

    [A case of mosaicism involving trisomy 21, maternal uniparental isodisomy, and normal diploid cells: Challenges and reflections in prenatal diagnosis].

    Xu C, Dong X, Xiong Y, Wang D

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2025; (42(8)):1006-1010 doi:10.3760/cma.j.cn511374-20250225-00108.

    PMID: 41070656
  19. 19

    Evaluation of Microfluidics-FISH method in prenatal diagnosis.

    Pietrzyk A, Ryłów M, Bryśkiewicz M, et al.

    Ginekologia polska 2017; (88(12)):670-673 doi:10.5603/GP.a2017.0119.

    PMID: 29303224

This page provides educational information about Down syndrome prenatal and postnatal testing. Always discuss your specific screening and diagnostic test results with your obstetrician or genetic counselor.

Stay up to date

Get notified when new research about Down syndrome is published.

No spam. Unsubscribe anytime.